Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy
The incidence of heart failure (HF) is generally preceded by cardiac hypertrophy (CH), which is the enlargement of cardiac myocytes in response to stress. During CH, the metabolism of arachidonic acid (AA), which is present in the cell membrane phospholipids, is modulated. Metabolism of AA gives rise to hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) via cytochrome P450 (CYP) ω-hydroxylases and CYP epoxygenases, respectively. A plethora of studies demonstrated the involvement of CYP-mediated AA metabolites in the pathogenesis of CH. Also, inflammation is known to be a characteristic hallmark of CH. In this review, our aim is to highlight the impact of inflammation on CYP-derived AA metabolites and CH. Inflammation is shown to modulate the expression of various CYP ω-hydroxylases and CYP epoxygenases and their respective metabolites in the heart. In general, HETEs such as 20-HETE and mid-chain HETEs are pro-inflammatory, while EETs are characterized by their anti-inflammatory and cardioprotective properties. Several mechanisms are implicated in inflammation-induced CH, including the modulation of NF-κB and MAPK. This review demonstrated the inflammatory modulation of cardiac CYPs and their metabolites in the context of CH and the anti-inflammatory strategies that can be employed in the treatment of CH and HF.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
---|---|
Enthalten in: |
Drug metabolism reviews - 55(2023), 1-2 vom: 13. Feb., Seite 50-74 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
ElKhatib, Mohammed A W [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 11.04.2023 Date Revised 23.05.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/03602532.2022.2162075 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350848629 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350848629 | ||
003 | DE-627 | ||
005 | 20231226045923.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/03602532.2022.2162075 |2 doi | |
028 | 5 | 2 | |a pubmed24n1169.xml |
035 | |a (DE-627)NLM350848629 | ||
035 | |a (NLM)36573379 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a ElKhatib, Mohammed A W |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.04.2023 | ||
500 | |a Date Revised 23.05.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The incidence of heart failure (HF) is generally preceded by cardiac hypertrophy (CH), which is the enlargement of cardiac myocytes in response to stress. During CH, the metabolism of arachidonic acid (AA), which is present in the cell membrane phospholipids, is modulated. Metabolism of AA gives rise to hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) via cytochrome P450 (CYP) ω-hydroxylases and CYP epoxygenases, respectively. A plethora of studies demonstrated the involvement of CYP-mediated AA metabolites in the pathogenesis of CH. Also, inflammation is known to be a characteristic hallmark of CH. In this review, our aim is to highlight the impact of inflammation on CYP-derived AA metabolites and CH. Inflammation is shown to modulate the expression of various CYP ω-hydroxylases and CYP epoxygenases and their respective metabolites in the heart. In general, HETEs such as 20-HETE and mid-chain HETEs are pro-inflammatory, while EETs are characterized by their anti-inflammatory and cardioprotective properties. Several mechanisms are implicated in inflammation-induced CH, including the modulation of NF-κB and MAPK. This review demonstrated the inflammatory modulation of cardiac CYPs and their metabolites in the context of CH and the anti-inflammatory strategies that can be employed in the treatment of CH and HF | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Inflammation | |
650 | 4 | |a arachidonic acid | |
650 | 4 | |a cardiac hypertrophy | |
650 | 4 | |a cytochrome P450 | |
650 | 4 | |a epoxyeicosatrienoic acid | |
650 | 4 | |a hydroxyeicosatetraenoic acid | |
650 | 4 | |a soluble epoxide hydrolase | |
650 | 7 | |a Cytochrome P-450 Enzyme System |2 NLM | |
650 | 7 | |a 9035-51-2 |2 NLM | |
650 | 7 | |a Arachidonic Acid |2 NLM | |
650 | 7 | |a 27YG812J1I |2 NLM | |
650 | 7 | |a Hydroxyeicosatetraenoic Acids |2 NLM | |
700 | 1 | |a Isse, Fadumo Ahmed |e verfasserin |4 aut | |
700 | 1 | |a El-Kadi, Ayman O S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug metabolism reviews |d 1973 |g 55(2023), 1-2 vom: 13. Feb., Seite 50-74 |w (DE-627)NLM000049530 |x 1097-9883 |7 nnns |
773 | 1 | 8 | |g volume:55 |g year:2023 |g number:1-2 |g day:13 |g month:02 |g pages:50-74 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/03602532.2022.2162075 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 55 |j 2023 |e 1-2 |b 13 |c 02 |h 50-74 |